At King Hussein Cancer Center, I adapt, validate, and customize decision-analytic economic models using institution-specific inputs and datasets. My work includes assessing cost-effectiveness and budget impact with decision trees and Markov models.
I conduct systematic literature searches and reviews to evaluate health technologies across oncology and non-oncology indications. I also critically appraise clinical and economic evidence and prepare HTA reports to inform reimbursement, formulary, and health system decisions.
In my Pharmacovigilance Officer role at King Hussein Cancer Center, I lead institutional activities for assessing, documenting, and reporting adverse drug reactions. I conduct signal detection and root-cause analyses and deliver training to support medication safety and patient safety.
As a Drug Information Pharmacist at King Hussein Cancer Center, I provide evidence-based drug information and respond to complex medication-related inquiries. I also support formulary management and medication policy development through evidence evaluation.

